Literature DB >> 31708243

An ex vivo technique for quantifying mouse lung injury using ultrasound surface wave elastography.

Boran Zhou1, Kyle J Schaefbauer2, Ashley M Egan3, Eva M Carmona Porquera4, Andrew H Limper4, Xiaoming Zhang5.   

Abstract

Idiopathic pulmonary fibrosis is a progressively fatal disease with limited treatments. The bleomycin mouse model is often used to simulate the disease process in laboratory studies. The aim of this study was to develop an ex vivo technique for assessing mice lung injury using lung ultrasound surface wave elastography (LUSWE) in the bleomycin mouse model. The surface wave speeds were measured at three frequencies of 100, 200, and 300 Hz for mice lungs from control, mild, and severe groups. The results showed significant differences in the lung surface wave speeds, pulse oximetry, and compliance between control mice and mice with severe pulmonary fibrosis. LUSWE is an evolving technique for evaluating lung stiffness and may be useful for assessing pulmonary fibrosis in the bleomycin mouse model.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bleomycin (BLM); Idiopathic pulmonary fibrosis (IPF); Lung ultrasound surface wave elastography (LUSWE); Mice; Surface wave speed

Mesh:

Year:  2019        PMID: 31708243      PMCID: PMC6930343          DOI: 10.1016/j.jbiomech.2019.109468

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  2 in total

1.  Lung mass density prediction using machine learning based on ultrasound surface wave elastography and pulmonary function testing.

Authors:  Boran Zhou; Brian J Bartholmai; Sanjay Kalra; Thomas Osborn; Xiaoming Zhang
Journal:  J Acoust Soc Am       Date:  2021-02       Impact factor: 1.840

2.  Grading Bleomycin-Induced Pulmonary Fibrosis in ex vivo Mouse Lungs Using Ultrasound Image Analysis.

Authors:  Boran Zhou; Juntao Shao; Kyle J Schaefbauer; Ashley M Egan; Eva M Carmona; Andrew H Limper; Xiaoming Zhang
Journal:  J Ultrasound Med       Date:  2020-08-31       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.